We’re excited and grateful to be selected for Venture Kick Stage 1 alongside such inspiring projects and founders! 🚀 Thank you to the Venture Kick team for believing in NanoZymeX and our mission to transform enzyme replacement therapies. Let’s keep pushing the boundaries of innovation in biotech! 🧬✨
CHF 10,000 for 4D-Picosense, Eureka , NanoZymeX, Optineura AI, and Permitree. These five projects were selected at Venture Kick's first financial and entrepreneurial support stage. https://lnkd.in/dP34bK42 Meet the five successful projects: Co-Founders: Thanushan Kugathasan, Giuseppe Iacobucci, Lorenzo Paolozzi, Roberto Cardella, Leonardo Cecconi, and Sriskaran Viros | 4D-Picosense - High-speed, reliable LiDAR sensing for autonomous vision. https://lnkd.in/dmKw22Nt CEO Siyi Zhang& CTO Yu Liu | Eureka - Making microscopes more accessible Margarita C. Dinamarca & Boris Sevarika | NanoZymeX - Delivering enzyme therapies precisely where they are needed https://lnkd.in/dn3KpwzV CEO Alex Donzelli | Optineura AI - Building a scalable deep learning platform for physics-based simulations. https://lnkd.in/d3QmXQv6 Co-founders Hanna Runets & Simon Iyamu Perisanidis | Permitree - Helping companies hire top global talent with the speed of AI. https://lnkd.in/dyFrrAXU #VentureKick #SwissStartups
🌟 Empowering Biotech Start-Ups in Rare Diseases | Connecting Innovators with Investors & Big Pharma | World Orphan Drug Congress Europe 2025
2moFantastic news! Look forward to hearing about your work at the World Orphan Drug Congress this October! 🚀